Cite
APA Citation
Rutgeerts, P., Gasink, C., Blank, M., Lang, Y., Johanns, J., Gao, L., Sands, B., Hanauer, S., Feagan, B., Targan, S., Ghosh, S., de Villiers, W., Colombel, J., Lee, S., Desreumaux, P., Loftus, E., Vermeire, S., & Sandborn, W. (n.d.). oC-005 A Multicenter, Double-Blind, Placebo (PBO)-Controlled Ph3 Study of Ustekinumab (UST), A Human IL-12/23P40 MAB, in Moderate-Severe Crohn's Disease (CD) Refractory to anti-TNFΑ: UNITI-1. Gut, 65, A3–A4. http://access.bl.uk/ark:/81055/vdc_100137790519.0x00004d